Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

704 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition).
Sun HC, Zhou J, Wang Z, Liu X, Xie Q, Jia W, Zhao M, Bi X, Li G, Bai X, Ji Y, Xu L, Zhu XD, Bai D, Chen Y, Chen Y, Dai C, Guo R, Guo W, Hao C, Huang T, Huang Z, Li D, Li G, Li T, Li X, Li G, Liang X, Liu J, Liu F, Lu S, Lu Z, Lv W, Mao Y, Shao G, Shi Y, Song T, Tan G, Tang Y, Tao K, Wan C, Wang G, Wang L, Wang S, Wen T, Xing B, Xiang B, Yan S, Yang D, Yin G, Yin T, Yin Z, Yu Z, Zhang B, Zhang J, Zhang S, Zhang T, Zhang Y, Zhang Y, Zhang A, Zhao H, Zhou L, Zhang W, Zhu Z, Qin S, Shen F, Cai X, Teng G, Cai J, Chen M, Li Q, Liu L, Wang W, Liang T, Dong J, Chen X, Wang X, Zheng S, Fan J; Alliance of Liver Cancer Conversion Therapy, Committee of Liver Cancer of the Chinese Anti-Cancer Association. Sun HC, et al. Among authors: teng g. Hepatobiliary Surg Nutr. 2022 Apr;11(2):227-252. doi: 10.21037/hbsn-21-328. Hepatobiliary Surg Nutr. 2022. PMID: 35464283 Free PMC article. Review.
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).
Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, Zhou W, Bie P, Liu L, Wen T, Han G, Wang M, Liu R, Lu L, Ren Z, Chen M, Zeng Z, Liang P, Liang C, Chen M, Yan F, Wang W, Ji Y, Yun J, Cai D, Chen Y, Cheng W, Cheng S, Dai C, Guo W, Hua B, Huang X, Jia W, Li Y, Li Y, Liang J, Liu T, Lv G, Mao Y, Peng T, Ren W, Shi H, Shi G, Tao K, Wang W, Wang X, Wang Z, Xiang B, Xing B, Xu J, Yang J, Yang J, Yang Y, Yang Y, Ye S, Yin Z, Zhang B, Zhang B, Zhang L, Zhang S, Zhang T, Zhao Y, Zheng H, Zhu J, Zhu K, Liu R, Shi Y, Xiao Y, Dai Z, Teng G, Cai J, Wang W, Cai X, Li Q, Shen F, Qin S, Dong J, Fan J. Zhou J, et al. Among authors: teng g. Liver Cancer. 2020 Dec;9(6):682-720. doi: 10.1159/000509424. Epub 2020 Nov 11. Liver Cancer. 2020. PMID: 33442540 Free PMC article.
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition).
Sun J, Guo R, Bi X, Wu M, Tang Z, Lau WY, Zheng S, Wang X, Yu J, Chen X, Fan J, Dong J, Chen Y, Cui Y, Dai C, Fang C, Feng S, Ji Z, Jia W, Jia N, Li G, Li J, Li Q, Li J, Liang T, Liu L, Lu S, Lv Y, Mao Y, Meng Y, Meng Z, Shen F, Shi J, Sun H, Tao K, Teng G, Wan X, Wen T, Wu L, Xia J, Ying M, Zhai J, Zhang L, Zhang X, Zhang Z, Zhao H, Zheng D, Zhi X, Zhou J, Zhou C, Zhou J, Zeng Z, Zhu K, Chen M, Cai J, Cheng S. Sun J, et al. Among authors: teng g. Liver Cancer. 2022 Mar 17;11(4):315-328. doi: 10.1159/000523997. eCollection 2022 Jul. Liver Cancer. 2022. PMID: 35978596 Free PMC article.
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.
Ren Z, Xu J, Bai Y, Xu A, Cang S, Du C, Li Q, Lu Y, Chen Y, Guo Y, Chen Z, Liu B, Jia W, Wu J, Wang J, Shao G, Zhang B, Shan Y, Meng Z, Wu J, Gu S, Yang W, Liu C, Shi X, Gao Z, Yin T, Cui J, Huang M, Xing B, Mao Y, Teng G, Qin Y, Wang J, Xia F, Yin G, Yang Y, Chen M, Wang Y, Zhou H, Fan J; ORIENT-32 study group. Ren Z, et al. Among authors: teng g. Lancet Oncol. 2021 Jul;22(7):977-990. doi: 10.1016/S1470-2045(21)00252-7. Epub 2021 Jun 15. Lancet Oncol. 2021. PMID: 34143971 Clinical Trial.
Expert consensus workshop report: Guidelines for thermal ablation of thyroid tumors (2019 edition).
Xu D, Ge M, Yang A, Cheng R, Sun H, Wang H, Zhang J, Cheng Z, Wu Z, Wang Z, Zhai B, Che Y, Chen L, Chen L, Cheng W, Dong G, Duan P, Fan W, Fei J, Fu R, Gao M, Huang P, Jiang T, Kuang J, Li H, Li P, Li X, Li Z, Lu M, Luo Y, Qin H, Qin J, Tan Z, Tang L, Wang Z, Wang S, Wang X, Wu G, Xie X, Xu H, Yin D, Qiu X, Jichun Y, Yu J, Zhan W, Zhang F, Zhang J, Zheng R, Zheng X, Zheng Y, Zhu Y, Zou Y, Meng Z, Ye X, Li H, Li X, Lin Z, Wang L, Wang L, Yang C, Wang Y, Zhou L, Ou D, Wang J, Gao M, Xu H, Liang P, Teng G. Xu D, et al. Among authors: teng g. J Cancer Res Ther. 2020 Sep;16(5):960-966. doi: 10.4103/jcrt.JCRT_558_19. J Cancer Res Ther. 2020. PMID: 33004735 Free article. Review.
Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.
Cheng AL, Amarapurkar D, Chao Y, Chen PJ, Geschwind JF, Goh KL, Han KH, Kudo M, Lee HC, Lee RC, Lesmana LA, Lim HY, Paik SW, Poon RT, Tan CK, Tanwandee T, Teng G, Park JW. Cheng AL, et al. Among authors: teng g. Liver Int. 2014 Feb;34(2):174-83. doi: 10.1111/liv.12314. Epub 2013 Nov 20. Liver Int. 2014. PMID: 24251922 Review.
A Prognostic Gene Signature for Hepatocellular Carcinoma.
Chen R, Zhao M, An Y, Liu D, Tang Q, Teng G. Chen R, et al. Among authors: teng g. Front Oncol. 2022 Apr 27;12:841530. doi: 10.3389/fonc.2022.841530. eCollection 2022. Front Oncol. 2022. PMID: 35574316 Free PMC article.
704 results